Open AccessP370: EARLY RESULTS OF A SAFETY AND EFFICACY STUDY OF ALLOGENEIC TRUUCAR™ GC502 IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B‐ALL)
Author(s) -
Li S.,
Yuan Z.,
Liu L.,
Li Y.,
Martina S.,
Liu J.,
Li Z.,
Wang X.,
He J.,
Zhao W.,
Shen L.,
Zhang X.,
Wang S.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844368.41871.e3
Subject(s) - medicine , blinatumomab , refractory (planetary science) , adverse effect , fludarabine , clinical trial , cd19 , oncology , immunology , leukemia , surgery , cyclophosphamide , lymphoblastic leukemia , antigen , chemotherapy , astrobiology , physics